Mission
To support the development of therapies for epilepsy and related comorbidities through research, education, and outreach.
Vision
A future without seizures and medication side effects and one that contributes to the discovery of innovative antiseizure medicines and promotes the training of next generation epilepsy scientist.
Values
Research that is driven by science.
Respect for our partnerships and the patients and community we serve.
Provide state-of-the-art training in the early discovery and characterization of antisiezure medicines using etiologically relevant approaches.
Strategy
Improve the lives of people living with epilepsy through the development and utilization of novel approaches and platforms that identify and advance transformative antiseizure medicines.
Educate and train the undergraduate, graduate, and professional student with an interest in translational epilepsy research in a collaborative environment.
Core Research Programs
Drug Resistant Epilepsy
- Rodent models of drug resistant seizures and epilepsy
- Novel drug discovery platforms
- Medication adherence
Novel Contributors to Epileptogenesis
- Neuroinflammation
- Comorbid conditions
Epilepsy Risk in Special Patient Groups
- Alzheimer’s disease associated risk genes
- Seizures in older people
Leadership Team
Jayanth Panyam
Dean, School of Pharmacy
Professor, Department of Pharmaceutics
Ryan Hansen
Chair, Department of Pharmacy
Professor of Pharmacy, Department of Pharmacy
Melissa Barker-Haliski
Co-Director
Associate Professor of Pharmaceutics
H. Steve White
Co-Director
Professor, Department of Pharmacy